ARTICLE | Company News
Amersham Pharmacia licenses VITX's Inactine
May 3, 2000 7:00 AM UTC
Amersham Pharmacia Biotech received exclusive worldwide distribution rights for V.I. Technologies' Inactine small molecule electrophilic nucleic acid binders virus inactivation technology. Separately,...